Evidence map›Paper›PMID 36269758›Full record

ArticlePLoS computational biology2022

Stochastic dynamics of Type-I interferon responses.

Benjamin D Maier, Luis U Aguilera, Sven Sahle, Pascal Mutz, Priyata Kalra, Christopher Dächert, Ralf Bartenschlager, Marco Binder, Ursula Kummer

Abstract read
In one paragraph

Article in PLoS computational biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Systems Virology at Scale.Current opinion in systems biology · 2025
    Article
  3. Review
  4. Development of a highly sensitive platform for protein-protein interaction detection and regulation of T cell function.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Benjamin D MaierDepartment of Modeling of Biological Processes, COS Heidelberg / Bioquant, Heidelberg University, Heidelberg, Germany.ORCID 0000-0001-8442-0536
Luis U AguileraDepartment of Modeling of Biological Processes, COS Heidelberg / Bioquant, Heidelberg University, Heidelberg, Germany.ORCID 0000-0003-0609-539X
Sven SahleDepartment of Modeling of Biological Processes, COS Heidelberg / Bioquant, Heidelberg University, Heidelberg, Germany.
Pascal MutzDivision Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-0430-2095
Priyata KalraDepartment of Modeling of Biological Processes, COS Heidelberg / Bioquant, Heidelberg University, Heidelberg, Germany.
Christopher DächertResearch Group "Dynamics of early viral infection and the innate antiviral response", German Cancer Research Center (DKFZ), Heidelberg, Germany.
Ralf BartenschlagerDivision Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Marco BinderResearch Group "Dynamics of early viral infection and the innate antiviral response", German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-5805-6109
Ursula KummerDepartment of Modeling of Biological Processes, COS Heidelberg / Bioquant, Heidelberg University, Heidelberg, Germany.ORCID 0000-0002-6413-2382

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interferon (IFN) activates the transcription of several hundred of IFN stimulated genes (ISGs) that constitute a highly effective antiviral defense program. Cell-to-cell variability in the induction of ISGs is well documented, but its source and effects are not completely understood. The molecular mechanisms behind this heterogeneity have been related to randomness in molecular events taking place during the JAK-STAT signaling pathway. Here, we study the sources of variability in the induction of the IFN-alpha response by using MxA and IFIT1 activation as read-out. To this end, we integrate time-resolved flow cytometry data and stochastic modeling of the JAK-STAT signaling pathway. The complexity of the IFN response was matched by fitting probability distributions to time-course flow cytometry snapshots. Both, experimental data and simulations confirmed that the MxA and IFIT1 induction circuits generate graded responses rather than all-or-none responses. Subsequently, we quantify the size of the intrinsic variability at different steps in the pathway. We found that stochastic effects are transiently strong during the ligand-receptor activation steps and the formation of the ISGF3 complex, but negligible for the final induction of the studied ISGs. We conclude that the JAK-STAT signaling pathway is a robust biological circuit that efficiently transmits information under stochastic environments.

Indexed as

Interferon Type IAntiviral AgentsInterferon-alphaSignal TransductionSTAT1 Transcription FactorAntiviral AgentsInterferon-alphaInterferon Type ISTAT1 Transcription Factor

Identifiers

PMID36269758
PMCPMC9629604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.